Jacob Kimmel

Jacob Kimmel is the Co-Founder and President of NewLimit, a pioneering biotechnology startup focused on developing epigenetic reprogramming therapeutics aimed at restoring youthful function in old cells and extending human healthspan. With a strong background in genomics, imaging, and machine learning, Jacob is dedicated to advancing the intersection of biology and technology to create innovative solutions in healthcare. He previously served as a data scientist at Calico Labs, where he contributed to research in aging and longevity.